腹膜透析与血液透析治疗糖尿病并发肾病的临床疗效比较  

Comparison of Clinical Efficacy of Peritoneal Dialysis and Hemodialysis in Treatment of Diabetic Complicated Nephropathy

作　　者：贺炜[1] 胡庆[1] 唐勇[1] 苟慧 韩雨梅[1] HE Wei;HU Qing;TANG Yong;GOU Hui;HAN Yu-mei(Department of Nephrology,Suining Central Hospital,Suining Sichuan 629000,China)

机构地区：[1]遂宁市中心医院肾内科

出　　处：《医学食疗与健康》2019年第13期40-41,共2页Medical Diet and Health

摘　　要：目的:研究比较糖尿病并发肾病患者采用腹膜透析与血液透析的临床疗效。方法:以我院于2018年8月-2019年8月期间收治的64例糖尿病并发肾病患者作为研究对象,依据病例单双号随机分为研究组和对照组,各32例,对照组患者采取血液透析,研究组患者采取腹膜透析,研究比较两组患者的临床疗效。结果:治疗后,两组组患者Ca、P水平无差异(P>0.05),ALB、PTH、SCr、BUN指标比较,两组患者差异显著(P<0.05)。并发症发生率指标比较,两组患者无差异(P>0.05)。结论:腹膜透析与血液透析均属于临床治疗糖尿病合并肾病的有效方式,腹膜透析保护患者肾功能效果更佳,临床可结合患者病情及各项生理指标合理选择。Objective:To compare the clinical efficacy of peritoneal dialysis and hemodialysis in patients with diabetic complicated nephropathy.Methods:64 patients with diabetic complicated nephropathy admitted to our hospital from August 2018 to August 2019 were randomly divided into a research group and a control group according to the single and double number of cases.32 cases each.Hie patients in the control group were treated with hemodialysis and the patients in the research group were treated with peritoneal dialysis.To compare the clinical effects of two groups of patients.Results:After the treatment,there was no difference in the levels of Ca and P in the two groups(P>0.05),and the ALB,PTH,SCr,and BUN indicators were compared,and the difference between the two groups was significant(P<UNK>0.05).There was no difference between the two groups(P>0.05).Conclusion:Peritoneal dialysis and hemodialysis are effective methods in the treatment of diabetes mellitus combined with nephropathy.The protective effect of peritoneal dialysis is better.

关 键 词：腹膜透析 血液透析 糖尿病合并肾病 

分 类 号：R459.5[医药卫生—治疗学]